These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33095522)

  • 1. Lupus Anticoagulant in Patients with Covid-19. Reply.
    Platton S; Bowles L; Pasi KJ
    N Engl J Med; 2020 Nov; 383(19):1893-1894. PubMed ID: 33095522
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.
    Gemcioglu E; Erden A; Davutoglu M; Karabuga B; Kucuksahin O
    J Clin Rheumatol; 2020 Sep; 26(6):236-237. PubMed ID: 32694351
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483).
    Tang N
    J Thromb Haemost; 2020 Aug; 18(8):2065-2066. PubMed ID: 32379935
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).
    Reyes Gil M; Barouqa M; Szymanski J; Gonzalez-Lugo JD; Rahman S; Billett HH
    JAMA Netw Open; 2020 Aug; 3(8):e2017539. PubMed ID: 32785632
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
    Galeano-Valle F; Oblitas CM; Ferreiro-Mazón MM; Alonso-Muñoz J; Del Toro-Cervera J; di Natale M; Demelo-Rodríguez P
    Thromb Res; 2020 Aug; 192():113-115. PubMed ID: 32425261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
    Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
    Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant is frequent in patients with Covid-19.
    Harzallah I; Debliquis A; Drénou B
    J Thromb Haemost; 2020 Aug; 18(8):2064-2065. PubMed ID: 32324958
    [No Abstract]   [Full Text] [Related]  

  • 8. Lupus Anticoagulant in Patients with Covid-19.
    Gooding R; Myers B; Salta S
    N Engl J Med; 2020 Nov; 383(19):1893. PubMed ID: 33095521
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
    Aubignat M; Godefroy O
    Rev Neurol (Paris); 2020 Jun; 176(6):505-506. PubMed ID: 32409176
    [No Abstract]   [Full Text] [Related]  

  • 10. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    Bowles L; Platton S; Yartey N; Dave M; Lee K; Hart DP; MacDonald V; Green L; Sivapalaratnam S; Pasi KJ; MacCallum P
    N Engl J Med; 2020 Jul; 383(3):288-290. PubMed ID: 32369280
    [No Abstract]   [Full Text] [Related]  

  • 11. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.
    Gris JC; Loubet P; Roger C; Cochery-Nouvellon E; Mauboussin JM; Muller L; Bouvier S; Laureillard D; Barbar SD; Mercier É; Lefrant JY; Sotto A
    J Thromb Haemost; 2020 Aug; 18(8):2068-2070. PubMed ID: 32495985
    [No Abstract]   [Full Text] [Related]  

  • 12. Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.
    Cárdenas Suri H; Jimomila Bening D
    Expert Rev Respir Med; 2020 Nov; 14(11):1071-1072. PubMed ID: 32746642
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to letter to the editor: catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.
    Robba C; Battaglini D; Pelosi P; Rocco PRM
    Expert Rev Respir Med; 2020 Nov; 14(11):1073-1074. PubMed ID: 32713214
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome.
    Hayden A; Vyas-Lahar A; Rella V; Rudinskaya A
    Lupus; 2020 Oct; 29(11):1472-1474. PubMed ID: 32640936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of lupus anticoagulant in COVID-19 patients.
    Harzallah I; Debliquis A; Drénou B
    J Thromb Haemost; 2020 Oct; 18(10):2778. PubMed ID: 32470207
    [No Abstract]   [Full Text] [Related]  

  • 16. A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant.
    Yarlagadda K; Mi K; Sendil S; Koons CL; Komanduri S; Cinicola JT
    Am J Case Rep; 2020 Aug; 21():e926623. PubMed ID: 32807764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".
    Coto-Hernández R; Fábregas Ruano MT
    J Thromb Haemost; 2020 Jun; 18(6):1519-1520. PubMed ID: 32302445
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'.
    Tang N
    J Thromb Haemost; 2020 Jun; 18(6):1520-1521. PubMed ID: 32302451
    [No Abstract]   [Full Text] [Related]  

  • 19. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
    Siguret V; Voicu S; Neuwirth M; Delrue M; Gayat E; Stépanian A; Mégarbane B
    Thromb Res; 2020 Nov; 195():74-76. PubMed ID: 32663703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.